Skip to main content

Cowen Prime Services LLC

SEC CIK
0001543830
Latest filing
Jul 16, 2021

The latest 13F from Cowen Prime Services LLC covers Q2 2021 (filed Jul 16, 2021): 167 long positions worth $275.7M. The top 10 holdings make up 54.6% of the portfolio, and the largest is PDF Solutions Inc (PDFS) at 12.5%. Livermore has 2 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2021

Share counts compared with Q1 2021: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
4
Est. +$715.0K
Added
23
Est. +$22.3M
Reduced
12
Est. −$10.5M
Sold out
10
Est. −$9.39M

Top 5 holdings

Share of this quarter's portfolio value

  1. PDFSPDF Solutions Inc
    12.5%$34.4MHistory
  2. QUOTQuotient Technology Inc.
    11.5%$31.6MHistory
  3. ASPNAspen Aerogels Inc
    5.0%$13.7MHistory
  4. Vonage Holdings Corp92886T201
    4.9%$13.6M
  5. INOVInovalon Holdings, Inc.
    4.8%$13.1MHistory

Share of portfolio

Top 5 holdings and the other 162 positions, by share of portfolio value

  1. PDFS12.5%
  2. QUOT11.5%
  3. ASPN5.0%
  4. Vonage Holdings Corp4.9%
  5. INOV4.8%
  6. Other 162 positions61.4%

Biggest buys

New and added positions, by estimated amount bought

  1. SCTLSocietal CDMO, Inc.
    +$5.30MAddedHistory
  2. GTYHGTY Technology Holdings Inc.
    +$3.73MAddedHistory
  3. PDFSPDF Solutions Inc
    +$3.15MAddedHistory
  4. SCORComscore, Inc.
    +$2.49MAddedHistory
  5. ASPNAspen Aerogels Inc
    +$2.09MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ASPNAspen Aerogels Inc
    +1.99 pp3.0% → 5.0%History
  2. SCTLSocietal CDMO, Inc.
    +1.82 pp0.5% → 2.3%History
  3. GTYHGTY Technology Holdings Inc.
    +1.44 pp1.3% → 2.8%History
  4. SCORComscore, Inc.
    +1.39 pp1.6% → 3.0%History
  5. PDFSPDF Solutions Inc
    +0.92 pp11.5% → 12.5%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. INOVInovalon Holdings, Inc.
    −$6.30MReducedHistory
  2. LABStandard Biotools Inc.
    −$4.44MSold outHistory
  3. Genmark Diagnostics Inc372309104
    −$4.18MSold out
  4. GANGAN Ltd
    −$1.13MReducedHistory
  5. RSSSResearch Solutions, Inc.
    −$740.8KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. LABStandard Biotools Inc.
    −1.68 pp1.7% → 0.0%History
  2. Genmark Diagnostics Inc372309104
    −1.58 pp1.6% → 0.0%
  3. INOVInovalon Holdings, Inc.
    −1.44 pp6.2% → 4.8%History
  4. GANGAN Ltd
    −0.55 pp1.0% → 0.5%History
  5. KOPNKopin Corp
    −0.21 pp0.8% → 0.6%History

Metrics

13F metrics for Q2 2021, computed only from the numbers in the filings. Definitions below.

Portfolio value
$275.7M
+$11.3M (+4.3%) vs. prior quarter
Positions
167
−6 vs. prior quarter
Top 10 concentration
54.6%
Top 10 as share of value
Turnover
7.3%
Q2 2021, one quarter
Average holding period
2.0 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

2 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $275.7M (Q2 2021)

Q1 2021: $264.4MQ2 2021: $275.7M
Q1 2021Q2 2021
13F filings of Cowen Prime Services LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2021Jul 16, 2021167$275.7MPDFSQUOTASPNvs. Q1 2021SEC
Q1 2021Apr 27, 2021173$264.4MQUOTPDFSINOV–SEC

13D and 13G filings

Companies where Cowen Prime Services LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

Cowen Prime Services LLC does not currently report owning 5% or more of any company.

Latest filings

7 filings on file made by Cowen Prime Services LLC or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by Cowen Prime Services LLC
CompanyFiled (ET)FormStakeChangeEvent dateFiling
NEPHNephros IncFeb 10, 202213GOld format–––SEC
NEPHNephros IncFeb 10, 202213GOld format–––SEC
NEPHNephros IncFeb 10, 202213GOld format–––SEC
NEPHNephros IncFeb 10, 202213GOld format–––SEC
NEPHNephros IncFeb 10, 202213GOld format–––SEC
RSSSResearch Solutions, Inc.Feb 16, 202113GOld format–New–SEC
NEPHNephros IncJan 27, 202113GOld format–New–SEC